Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. - Wikidata - wikimedia - TriplyDB

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.

http://www.wikidata.org/entity/Q34640885

about

Neuroplasticity and the next wave of antidepressant strategies Ketamine use in current clinical practice Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy Ketamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on Efficacy Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics Pharmacological approaches to the challenge of treatment-resistant depression Antidepressant mechanism of ketamine: perspective from preclinical studies Contribution of NMDA receptors to dorsolateral prefrontal cortical networks in primates Ketamine, sleep, and depression: current status and new questions Antidepressant actions of ketamine: from molecular mechanisms to clinical practice Signal Transduction in Astrocytes during Chronic or Acute Treatment with Drugs (SSRIs, Antibipolar Drugs, GABA-ergic Drugs, and Benzodiazepines) Ameliorating Mood Disorders Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy A brief history of the development of antidepressant drugs: from monoamines to glutamate Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing l-DOPA-Induced Dyskinesias A neurocognitive model for understanding treatment action in depression The positive effect on ketamine as a priming adjuvant in antidepressant treatment.Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats.Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain.Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats.Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice.Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamine.A randomized controlled trial of intranasal ketamine in major depressive disorder.Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects.Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects.Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics The role of ketamine in treatment-resistant depression: a systematic review.Glutamate NMDA receptor modulators for the treatment of depression: trials and tribulations.Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.Investigational drugs in recent clinical trials for treatment-resistant depression.Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.Repeated S-ketamine infusions in therapy resistant depression: a case series.Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

P2860

Q21129480-31DD4622-919A-48A2-8674-2183BAA14CE2 Q26750682-E921E5E6-48D2-4C6A-91B8-0B31192348FE Q26773084-9C1CEEE2-DAAF-4E13-8B59-C8E661CEEC84 Q26778251-4613ABC5-E133-4D68-9E19-5DE93019EAE5 Q26782274-6409741D-E03A-439A-8EDF-4A899B7197EB Q26782993-F0ED7582-3C07-48A3-BE12-432846B0EA32 Q26782997-CEF2A01A-8ED3-439B-9551-8A27C7D4F378 Q26798241-9ED2D319-C745-47EE-B8B9-D72B90BC342C Q26800231-BE2CFB0A-4629-4A89-8EBE-F8933A2532CC Q26820417-53530530-61C0-4C4E-87E9-E006095D06C6 Q26828564-117C1B84-561A-4608-A2FC-7C0230A51A50 Q26995879-20498828-98E1-45AC-BB1E-A682C49453D2 Q27006485-12FEE688-1616-41D0-91BB-7D7B653F6664 Q27024227-8092DD16-ED1E-40A2-B129-7FC4CA049699 Q27028050-21832181-05C8-44A0-9236-90E86B1E8D46 Q28396103-E857CA6F-0734-4422-97F4-032D109CE239 Q28828342-3E758730-DEDA-4960-879C-67D440E9BED4 Q30374324-73BEF58A-EA07-4B90-9749-8637F868CBE6 Q30408646-ED3AC796-6BF3-4DB0-97D8-C674A9610397 Q30547324-10F5002D-C54C-4977-85E8-26E005E25B0D Q30711088-197498FE-941E-4953-A538-CC3FDF896147 Q30987882-548993B4-6AE2-4826-BF71-C89DF6E799AE Q33693374-CCA90C99-A7D2-4045-BBEA-CB1AC06C59F3 Q33758450-1354A256-AA7D-4116-8F39-22E0EAF68437 Q33864745-CC50C2DB-9E21-40E4-B1AF-4A50EEA5BCDA Q33874459-408FCB6E-736B-44EA-A2E5-FFD23A8613DE Q34241455-C8B463B1-E7C7-43A1-8B34-16E3EF53CE48 Q34288196-3130CB44-8EAB-482D-A206-A242CDA4BB3D Q34333515-CA862E36-6E33-492E-9917-233CE98352EF Q34391633-DFD3798A-41F7-46F7-877F-6B31BED05291 Q34436340-E8C46471-16C2-45ED-86DD-53282D9B8DFE Q34444632-8A58B159-12A9-4AFF-8B9A-A042F1970210 Q34449588-2887F0BA-5724-4223-AEE5-5C617367420B Q34466310-46877C19-4D9E-4658-8361-1557B5C91FE5 Q34475595-29D748B6-91F7-46FD-9831-902405D0BF4A Q34549390-22AE2EDA-C3CD-4C0F-B823-DEC27AA30B62 Q34551188-DC877E59-9581-4422-A18F-6AB7C9C64D38 Q34653386-03C3311A-8425-47EC-9ED4-61A1A5678D3C Q34654747-7F0FE0E2-C51A-4D9D-B8CA-FC01D0E1E1A3 Q34655680-E751E062-004C-44AF-BA2D-8DDF937B90C0

P2860

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.

http://www.wikidata.org/entity/Q34640885

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Rapid and longer-term antidepr ...... nt-resistant major depression.

@ast

Rapid and longer-term antidepr ...... nt-resistant major depression.

@en

Rapid and longer-term antidepr ...... nt-resistant major depression.

@nl

type

label

Rapid and longer-term antidepr ...... nt-resistant major depression.

@ast

Rapid and longer-term antidepr ...... nt-resistant major depression.

@en

Rapid and longer-term antidepr ...... nt-resistant major depression.

@nl

prefLabel

Rapid and longer-term antidepr ...... nt-resistant major depression.

@ast

Rapid and longer-term antidepr ...... nt-resistant major depression.

@en

Rapid and longer-term antidepr ...... nt-resistant major depression.

@nl

P1433

Q34640885-8E1B61ED-C787-45C4-925B-3433D9D37E13

P1476

Q34640885-A7327957-0F87-4734-9B8E-AB5AEC61185D

P2093

Q34640885-11AC0A7D-64CD-4B3F-80D6-31CA2152F2C1

Q34640885-4538A11A-2223-4C77-AD33-CB60DCAB0F84

Q34640885-5BC567F8-12B8-4B40-91A7-F1E41A248A23

Q34640885-6BA7B6B8-98DE-4643-AE7B-2C54406D1DDB

Q34640885-835A7E42-ECFE-47E5-9502-6AED3CB4EA44

Q34640885-861ED377-6B6D-4739-913A-7BB327D6FECB

Q34640885-969C2862-4102-4340-AEE4-F898BB0DBB7C

Q34640885-A5909AEE-1BF3-4274-9E50-9A14622C7EDF

Q34640885-B94D8F4B-A5C4-4726-BEF9-80B0B01FDBD7

P2860

Q34640885-07CE3B72-CCCB-4B26-A157-60DB69E727EA

Q34640885-1785F2A9-4132-49E6-93AC-8825BAD5BA07

Q34640885-199DBE1F-863F-4F96-9589-60AB491E6BA6

Q34640885-1C460CFD-1FD4-4D7E-AF14-86B53EAC44BA

Q34640885-2EB95D70-82DB-4D71-89CE-5216190CEBD4

Q34640885-31E27C6D-9A06-4944-B526-3B945F5CC118

Q34640885-37FF5A65-A4A6-43BE-B5D7-B0C4FB85CDE3

Q34640885-42E18F0B-5C10-4724-97A7-9493FDC14AE4

Q34640885-4F9E2590-B254-4FB1-9BDA-3C788D2AC4B9

Q34640885-52993D01-A8A9-4AA2-A347-A6CB753ADA79

P304

Q34640885-321085B5-0FD2-47D2-A2F0-E25001382ED0

P31

Q34640885-A4B1F570-C1E3-4A9A-8283-2FFDA090E9B2

P356

Q34640885-CF7A1C05-A166-477C-9869-79386BAF26DE

P407

Q34640885-20B37676-6712-42C8-9874-63CDAA26DDFE

P433

Q34640885-D8B1E539-7068-4D5C-9C5C-7C95CD166309

P478

Q34640885-FEEDA2D6-3C66-4B3F-A982-7E42EF30FD7A

P50

Q34640885-C43AB09A-A8A0-4B24-9AD3-05425952817B

P577

Q34640885-B0EF378D-E68C-4D5F-9C4A-476ECA5C4237

P5875

Q34640885-D1E5CC17-2596-434A-98C9-04B38C1E6790

P698

Q34640885-C9C3E2B7-90AB-4C6C-B7EC-C47AEF199038

P932

Q34640885-AFECC171-CF40-4B41-B97A-B68F202E7D92

P356

J.BIOPSYCH.2012.06.022

P1433

Biological Psychiatry

P1476

Rapid and longer-term antidepr ...... nt-resistant major depression.

@en

P2093

Andrew M Perez

http://www.w3.org/2001/XMLSchema#string

Dan V Iosifescu

http://www.w3.org/2001/XMLSchema#string

Dennis S Charney

http://www.w3.org/2001/XMLSchema#string

James W Murrough

http://www.w3.org/2001/XMLSchema#string

Jessica Stern

http://www.w3.org/2001/XMLSchema#string

Katherine A Collins

http://www.w3.org/2001/XMLSchema#string

Michael K Parides

http://www.w3.org/2001/XMLSchema#string

Sanjay J Mathew

http://www.w3.org/2001/XMLSchema#string

Sarah Pillemer

http://www.w3.org/2001/XMLSchema#string

P2860

Grand challenges in global mental health

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

NMDA antagonist neurotoxicity: mechanism and prevention

A new depression scale designed to be sensitive to change

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

Antidepressant effects of ketamine in depressed patients

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

P304

250-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2012.06.022

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

Marije Aan Het Rot

P577

2012-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230575901

http://www.w3.org/2001/XMLSchema#string

P698

22840761

http://www.w3.org/2001/XMLSchema#string

P932

3725185

http://www.w3.org/2001/XMLSchema#string